Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ1V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,668
Award facts
- Contract value 100% obligated
- $65,667.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $65,667.69 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Dupixent (dupilumab) is a biologic medication commonly prescribed for moderate-to-severe eczema, asthma, and other allergic conditions, representing a specialty pharmaceutical product within the Defense Health Agency's medical supply requirements for service members and military beneficiaries. AmerisourceBergen's role as a prime vendor through the DLA Troop Support Medical IDC positions the company to efficiently fulfill critical pharmaceutical needs across the military's global healthcare network, including support for military treatment facilities and other federal medical institutions. The short completion timeline reflects the urgent medical supply requirements typical of federal pharmaceutical procurement operations.
Quick answers
Who was awarded contract SPE2DR26FCZ1V?
SPE2DR26FCZ1V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FCZ1V worth?
The government has obligated $65,668 on SPE2DR26FCZ1V.
Is contract SPE2DR26FCZ1V an order under another contract?
Yes. SPE2DR26FCZ1V is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ1V competed?
The extent of competition for SPE2DR26FCZ1V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award